Table 1 Patients’ characteristics at different radiotherapy duration
From: Comparing neoadjuvant long-course chemoradiotherapy with short-course radiotherapy in rectal cancer
Clinical variable | Radiotherapy duration | χ2 | P value | |
|---|---|---|---|---|
SC (%) | LC (%) | |||
Age Median (IQR), years | 59 (49–65) | 53 (45–60) | – | 0.01* |
Sex | ||||
Male Female | 18 (56.25) 14 (43.75) | 87 (63.04) 51 (36.96) | 0.51 | 0.48** |
Distance to anus | ||||
≤ 5 cm > 5 cm | 23 (71.88) 9 (28.12) | 85 (61.59) 53 (38.41) | 1.19 | 0.28** |
Mode of operation | ||||
Open abdomen Endoscopic | 6 (18.75) 26 (81.25) | 73 (52.90) 65 (47.10) | 12.18 | < 0.01** |
Type of operation | ||||
Dixon Hartmann Miles | 20 (62.50) 0 (0.00) 12 (37.50) | 87 (63.04) 4(2.90) 47(34.06) | – | 0.93*** |
Neoadjuvant chemotherapy | ||||
No Yes | 5 (15.63) 27 (84.37) | 36 (26.09) 102 (73.91) | 1.55 | 0.21** |
CEA Median (IQR), ng/mL | 2.74 (1.55–5.39) | 3.95 (1.81–15.27) | – | 0.11* |
Clinical tumor stage | ||||
cT2 cT3 cT4 | 4 (12.50) 23 (71.88) 5 (15.62) | 4 (2.90) 97 (70.29) 37 (26.81) | 5.42 | 0.08** |
Lymph node status | ||||
Negative Positive | 2 (6.25) 30 (93.75) | 20 (14.49) 118 (85.51) | 0.92 | 0.34** |